Astellas Pharma is pleased to announce the appointment of Şeyma Bahşi, as the Area Head of Turkey, Middle East, and Africa (T-MEA) effective from October 1, 2024. In her new role, she will lead operations across 12 markets, serving a population of over 418 million people. She will continue to power Astellas Turkey until a new General Manager is appointed.
According to Industry sources, Şeyma carries over 23 years of expertise in the healthcare sector. Her career with Astellas began in 2016 as Sales Director for Astellas Turkey. She later served as General Manager of Astellas Singapore & Malaysia, where she successfully led organizational transformation and significantly grew revenues and profitability. Most recently, in 2023, she returned to Turkey as General Manager.
Commenting on her appointment, Leon Moore, President of International Markets Commercial at Astellas, stated: “Şeyma has consistently demonstrated exceptional leadership and a deep commitment to Astellas’ mission of improving patient outcomes. Her experience, vision, and ability to drive transformation make her the ideal leader for the T-MEA area. We are confident that under her leadership, Astellas will continue to grow and make a meaningful difference in the healthcare landscape across these markets.”
Industry sources added that Şeyma will report directly to the President of International Markets and will be based in Istanbul. As a member of the International Markets Leadership Team (IMLT), her role will focus on driving Astellas’ vision of transforming innovative science into value for patients across the T-MEA area.
